Literature DB >> 19705236

Strategy of surgery and radiation therapy for brain metastases.

Yoshitaka Narita1, Soichiro Shibui.   

Abstract

Cancer patients with brain metastases have poor prognoses and their median survival time is about 1 year. Surgery with whole-brain radiation therapy (WBRT) has been used in the treatment of single brain metastasis measuring 3 cm or more. Stereotactic radiosurgery (SRS) including the use of the Gamma knife and Cyberknife is widely used for the treatment of small and multiple brain metastases; however, recent clinical studies have revealed that SRS + WBRT is superior to WBRT or SRS alone in terms of survival time and local tumor control rates. Here, surgical indications and the strategy of surgery and radiation therapy are discussed, based on many clinical trials of treatments for brain metastases. To improve the survival rate and quality of life for these cancer patients with brain metastases, it is necessary to choose the most suitable mode of surgery and radiotherapy with the close cooperation of physicians, surgeons, radiologists, and neurosurgeons, based on accumulated evidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705236     DOI: 10.1007/s10147-009-0917-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  27 in total

1.  Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  M J Glantz; B F Cole; P A Forsyth; L D Recht; P Y Wen; M C Chamberlain; S A Grossman; J G Cairncross
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

Review 3.  Management of brain metastases.

Authors:  Riccardo Soffietti; Roberta Rudā; Roberto Mutani
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

4.  Resection of brain metastases previously treated with stereotactic radiosurgery.

Authors:  Giacomo G Vecil; Dima Suki; Marcos V C Maldaun; Frederick F Lang; Raymond Sawaya
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

5.  Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Authors:  P K Sneed; K R Lamborn; J M Forstner; M W McDermott; S Chang; E Park; P H Gutin; T L Phillips; W M Wara; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

6.  Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

Authors:  Christina Hempen; Elisabeth Weiss; Clemens F Hess
Journal:  Support Care Cancer       Date:  2002-02-09       Impact factor: 3.603

7.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 8.  Interactions between antiepileptic and chemotherapeutic drugs.

Authors:  Charles J Vecht; G Louis Wagner; Erik B Wilms
Journal:  Lancet Neurol       Date:  2003-07       Impact factor: 44.182

Review 9.  Leptomeningeal metastases.

Authors:  Alexis Demopoulos
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

10.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

View more
  15 in total

Review 1.  Neurosurgical management of metastases in the central nervous system.

Authors:  Elizabeth B Claus
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population.

Authors:  Jia Jin; Xinli Zhou; Xiaohua Liang; Ruofan Huang; Zhaohui Chu; Jingwei Jiang; Qiong Zhan
Journal:  J Neurooncol       Date:  2010-10-27       Impact factor: 4.130

3.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

Review 4.  [Prognostic biomarkers for metastatic colorectal cancer].

Authors:  J H L Neumann
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

5.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

6.  Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis.

Authors:  Hiroshi Mayahara; Minako Sumi; Yoshinori Ito; Syuhei Sekii; Kana Takahashi; Kouji Inaba; Yuuki Kuroda; Naoya Murakami; Madoka Morota; Jun Itami
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-23       Impact factor: 4.553

7.  Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center.

Authors:  Jia Jin; Xinli Zhou; Xiaohua Liang; Ruofan Huang; Zhaohui Chu; Jingwei Jiang; Qiong Zhan
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-04       Impact factor: 4.553

8.  Cerebral metastasis from a previously undiagnosed appendiceal adenocarcinoma.

Authors:  Antonio Biroli; Paolo Cipriano Cecchi; Susanne Pragal; Esther Hanspeter; Andreas Schwarz
Journal:  Case Rep Oncol Med       Date:  2012-11-01

9.  Surgery for brain metastases.

Authors:  Kurt Andrew Yaeger; M Nathan Nair
Journal:  Surg Neurol Int       Date:  2013-05-02

10.  Surgical resection of brain metastases-impact on neurological outcome.

Authors:  Petra Schödel; Karl-Michael Schebesch; Alexander Brawanski; Martin Andreas Proescholdt
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.